Giant Cell Tumor of the Larynx Treated by Surgery and Adjuvant Denosumab: Case Report and Review of the Literature

Giant cell tumor of the larynx (GCTL) is a rare entity; only 34 cases have been reported in the literature. We report a case of GCTL in a 46 year-old male presenting clinical, radiographic, histological and therapeutic features. Previously reported cases are also reviewed.

Saved in:
Bibliographic Details
Published inHead & neck pathology (Totowa, N.J.) Vol. 9; no. 4; pp. 447 - 452
Main Authors Yancoskie, Aaron E., Frank, Douglas K., Fantasia, John E., Savona, Steven, Eiseler, Nicole, Reder, Ilan, Kahn, Leonard B.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.12.2015
Subjects
Antineoplastic Agents - therapeutic use
Chemotherapy, Adjuvant
Denosumab - therapeutic use
Dentistry
Giant Cell Tumors - pathology
Giant Cell Tumors - therapy
Humans
Laryngeal Neoplasms - pathology
Laryngeal Neoplasms - therapy
Male
Medicine
Medicine & Public Health
Middle Aged
Oral and Maxillofacial Surgery
Original Paper
Otorhinolaryngologic Surgical Procedures
Otorhinolaryngology
Pathology
Larynx
Head and neck surgery
Denosumab
Giant cell
Online AccessGet full text

Cover

More Information
Summary:Giant cell tumor of the larynx (GCTL) is a rare entity; only 34 cases have been reported in the literature. We report a case of GCTL in a 46 year-old male presenting clinical, radiographic, histological and therapeutic features. Previously reported cases are also reviewed.
Bibliography:ObjectType-Case Study-3
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Review-1
ObjectType-Feature-5
ObjectType-Report-2
ObjectType-Article-4
ISSN:1936-055X
1936-0568
DOI:10.1007/s12105-015-0622-4